scholarly journals Association between APE1 Asp148Glu polymorphism and the risk of urinary cancers: a meta-analysis of 18 case–control studies

2016 ◽  
pp. 1499
Author(s):  
Jue-Yu Zhou ◽  
Jie hui Zhong ◽  
Zheng Zhao ◽  
Jie Liu ◽  
Hai-Lang Yu ◽  
...  
Keyword(s):  
Meta Analysis ◽  
Ape1 Asp148glu

The association between the APE1 Asp148Glu polymorphism and prostate cancer susceptibility: a meta-analysis based on case–control studies

2014 ◽  
Vol 290 (1) ◽  
pp. 281-288 ◽  
Author(s):  
Xue Zhou ◽  
Li Wei ◽  
Guangjun Jiao ◽  
Wei Gao ◽  
Mingzhen Ying ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Susceptibility ◽  
Meta Analysis ◽  
Case Control ◽  
Case Control Studies ◽  
Prostate Cancer Susceptibility ◽  
Ape1 Asp148glu

The association between the APE1 Asp148Glu polymorphism and breast cancer susceptibility: a meta-analysis based on case–control studies

Tumor Biology ◽  
2014 ◽  
Vol 35 (5) ◽  
pp. 4727-4734 ◽  
Author(s):  
Zhiyong Zhao ◽  
Chuan Liu ◽  
Yong Zeng ◽  
Lei Gu ◽  
Mingzhen Ying ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Susceptibility ◽  
Meta Analysis ◽  
Breast Cancer Susceptibility ◽  
Case Control ◽  
Case Control Studies ◽  
Ape1 Asp148glu

scholarly journals Letter regarding Shen et al. entitled “The APE1 Asp148Glu polymorphism and colorectal cancer susceptibility: a meta-analysis”

Tumor Biology ◽  
2014 ◽  
Vol 35 (12) ◽  
pp. 12775-12776
Author(s):  
Fei Liu ◽  
Yong-Gang Wei ◽  
Wen-Tao Wang ◽  
Bo Li
Keyword(s):  
Colorectal Cancer ◽  
Cancer Susceptibility ◽  
Meta Analysis ◽  
Ape1 Asp148glu

The APE1 Asp148Glu polymorphism and colorectal cancer susceptibility: a meta-analysis

Tumor Biology ◽  
2013 ◽  
Vol 35 (3) ◽  
pp. 2529-2535 ◽  
Author(s):  
Erdong Shen ◽  
Chuan Liu ◽  
Li Wei ◽  
Jianbing Hu ◽  
Jie Weng ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Cancer Susceptibility ◽  
Meta Analysis ◽  
Ape1 Asp148glu

The association of APE1 Asp148Glu gene polymorphisms and lung cancer risk: an updated meta-analysis

Tumor Biology ◽  
2013 ◽  
Vol 35 (4) ◽  
pp. 3597-3603 ◽  
Author(s):  
Wen Chen ◽  
Qin Wang ◽  
Mang Liu ◽  
Xiao-bing Ding
Keyword(s):  
Lung Cancer ◽  
Cancer Risk ◽  
Gene Polymorphisms ◽  
Lung Cancer Risk ◽  
Meta Analysis ◽  
Ape1 Asp148glu

APE1 Asp148Glu gene polymorphism and lung cancer risk: a meta-analysis

2010 ◽  
Vol 38 (7) ◽  
pp. 4537-4543 ◽  
Author(s):  
Ya-Nan Ji ◽  
Ping Zhan ◽  
Jing Wang ◽  
Li-Xin Qiu ◽  
Li-Ke Yu
Keyword(s):  
Lung Cancer ◽  
Cancer Risk ◽  
Gene Polymorphism ◽  
Lung Cancer Risk ◽  
Meta Analysis ◽  
Ape1 Asp148glu

APE1 Asp148Glu gene polymorphism and bladder cancer risk: a meta-analysis

2012 ◽  
Vol 40 (1) ◽  
pp. 171-176 ◽  
Author(s):  
Chuan Liu ◽  
Qinghua Yin ◽  
Lian Li ◽  
Ying-zhi Zhuang ◽  
Xuyu Zu ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Cancer Risk ◽  
Gene Polymorphism ◽  
Meta Analysis ◽  
Bladder Cancer Risk ◽  
Ape1 Asp148glu

scholarly journals Association between APE1 ASP148GLU and colorectal cancer risk: A meta-analysis

2020 ◽  
Vol 43 (4) ◽  
pp. E24-34
Author(s):  
Caizhao Lin ◽  
Yuewei Jin ◽  
Shaobing Cheng ◽  
Weibing Wang
Keyword(s):  
Colorectal Cancer ◽  
Meta Analysis ◽  
Additive Model ◽  
Recessive Model ◽  
Cochrane Library ◽  
Dominant Model ◽  
Common Cancer ◽  
Pcr Rflp ◽  
Subgroup Analyses ◽  
Ape1 Asp148glu

Background: Colorectal cancer (CRC) is recognized as one of the most common cancer globally. The association between CRC and apurinic endonuclease 1 (APE1) Asp148Glu polymorphism remains unclear; thus, this meta-analysis aimed to explore whether APE1 Asp148Glu polymorphism is related to CRC risk. Methods: Embase, PubMed, Cochrane library, CNKI and Wanfang databases were subject to a systematic search until April, 17, 2020 to evaluate the effect of APE1 Asp148Glu polymorphism on CRC risk. The associated strength was used to evaluate with odds ratios (ORs) with 95% confidence intervals (CIs) between Asp148Glu polymorphism and CRC risk. Subgroup analyses were also performed. Results: In total, 11 articles including 8,136 subjects (3,836 cases and 4,300 controls) were included. Five genetic models were analyzed, including the additive model (G vs. T), the heterozygote comparison (TG vs. TT), the homozygote comparison (GG vs. TT), the dominant model (TG+GG vs. TT), and the recessive model (GG vs. TG+TT). In these models, T refers to thymine and G refers to guanine. The APE1 Asp148Glu polymorphism in heterozygote comparison [OR (95%CI) = 1.36 (1.05, 1.75), P=0.019] and dominant model [OR (95%CI) =1.31 (1.07, 1.61), P=0.010] significantly increased CRC risk. No significant association was seen for the additive model [OR (95%CI) = 1.14 (1.00, 1.31), P=0.057], recessive model [OR (95%CI) = 0.97 (0.71, 1.31), P=0.826] or in homozygote comparison [OR (95%CI) = 1.15 (0.88, 1.52), P=0.309]. Moreover, CRC risk indicated a remarkable association with APE1 Asp148Glu polymorphism in the PCR-RFLP additive model, homozygote comparison and recessive model (PG) may be a potential risk factor for CRC.

The effects of low-ratio n-6/n-3 PUFA on biomarkers of inflammation: a systematic review and meta-analysis

2021 ◽  
Author(s):  
Yali Wei ◽  
Yan Meng ◽  
Na Li ◽  
Qian Wang ◽  
Liyong Chen
Keyword(s):  
Systematic Review ◽  
Fatty Acid ◽  
Polyunsaturated Fatty Acid ◽  
Meta Analysis ◽  
Chain Polyunsaturated Fatty Acid ◽  
Inflammation Markers ◽  
Pufa Supplementation ◽  
Long Chain

The purpose of the systematic review and meta-analysis was to determine if low-ratio n-6/n-3 long-chain polyunsaturated fatty acid (PUFA) supplementation affects serum inflammation markers based on current studies.

Sign in / Sign up

Export Citation Format

Share Document